EQS Group AG

EQS Group is a leading international technology provider for Investor Relations, Corporate Communications, and Corporate Compliance. More than 8,000 companies worldwide use EQS Group’s offerings to fulfill complex national and international disclosure obligations, to minimize risk, and to reach stakeholder.

EQS Group is a digital single-source provider for global teams. EQS Group’s products and services include a global newswire, regulatory news distribution, investor targeting and contact management, and insider list management. These are integrated within a cloud-based platform, the EQS COCKPIT, to streamline the workflows of Investor Relations, Communications, and Compliance professionals. The Group also offers an innovative whistleblowing and case management software, IR website services, digital reports, and webcasting solutions.

EQS Group was founded in 2000 in Munich, Germany. Today, the group employs over 400 professionals around the globe and has offices in the world’s key financial markets.

 PRESS RELEASE

EQS-News: Defence Therapeutics Inc.: DEFENCE BEGINNT MIT TESTS SEINES ...

EQS-News: Defence Therapeutics Inc. / Schlagwort(e): Sonstiges Defence Therapeutics Inc.: DEFENCE BEGINNT MIT TESTS SEINES ARM-IMPFSTOFFS GEGEN PANKREASKREBS 06.06.2023 / 11:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.                                                                     _________________________________________________________________ CSE: DTC   Börse Frankfurt: DTC    USOTC:DTCFF  PRESSEMITTEILUNGDEFENCE BEGINNT MIT TESTS SEINES ARM-IMPFSTOFFS GEGEN PANKREASKREBSVancouver, British Columbia, Kanada, den 6. Juni 2...

 PRESS RELEASE

Hardman & Co Video | Chesnara (CSN) Presentation and Q&A with Manageme...

Hardman & Co Research Hardman & Co Video | Chesnara (CSN) Presentation and Q&A with Management 06-Jun-2023 / 10:30 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman Talks Video | Chesnara Presentation and Q&A with Management In this edition of Hardman Talks we were joined by the senior management of Surface Transforms, an established Life and Pensions Consolidator in the UK and Europe. Watch it here: Chief Executive Steve Murray and Group Finance Director David Rimmington discuss Chesnara’s FY22 results and progress with analyst Brian Mo...

 PRESS RELEASE

EQS-News: Erstmals über 60 Emittenten auf C-Level auf dem HIT

EQS-News: Montega AG / Schlagwort(e): Konferenz Erstmals über 60 Emittenten auf C-Level auf dem HIT 06.06.2023 / 11:05 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Erstmals über 60 Emittenten auf C-Level auf dem HIT Am 23. und 24. August laden Montega und ihr strategischer Kapitalmarktpartner DONNER & REUSCHEL zu den bereits 10. Hamburger Investorentagen ein. Der Jubiläums-HIT bietet dabei ein ganz besonderes (Rahmen-)Programm: Zum Auftakt lockt ein spektakuläres Vorabendevent im 20up – einer außergewöhnlichen Bar mit einer sensati...

 PRESS RELEASE

Next Block Expo (NBX) Concludes Successful Second Edition in Warsaw, C...

Chainwire Next Block Expo (NBX) Concludes Successful Second Edition in Warsaw, Celebrating A Dynamic Web 3.0 Landscape 06-Jun-2023 / 09:44 GMT/BST The issuer is solely responsible for the content of this announcement. Next Block WARSAW, POLAND, JUNE 05, 2023 - The second edition of the (NBX) has recently concluded in Warsaw, Poland, with impressive results highlighting the vibrant energy and forward momentum of the Web 3.0 ecosystem. The event, held at the Multikino Zlote Tarasy Warsaw venue on May 24-25, saw the attendance of 1,583 participants, hosting 88 speakers, 25 exhibitor...

 PRESS RELEASE

EQS-News: MPH Health Care AG: Q1 result 2023

EQS-News: MPH Health Care AG / Key word(s): Quarterly / Interim Statement MPH Health Care AG: Q1 result 2023 06.06.2023 / 10:25 CET/CEST The issuer is solely responsible for the content of this announcement. MPH Health Care AG: Q1 result 2023 Preliminary IFRS result for the first quarter of 2023 published. Equity capital (net asset value) amounts to EUR 188.0 million. This corresponds to EUR 43.91 per share (previous year's quarter Q1/2022: EUR 44.00). The equity ratio is 92.8 %. Berlin, 6 June 2023 - MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFR...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch